All News #Library
Biotech
Walden Biosciences Appoints Howard Mayer to Board of Directors
28 Jan 2025 //
GLOBENEWSWIRE
Walden Bio Highlights 2024 Accomplishments and 2025 Priorities
10 Jan 2025 //
GLOBENEWSWIRE
Walden Biosciences Enrolls First Cohort In Ph 2 Kidney Study
30 Sep 2024 //
GLOBENEWSWIRE
Walden Biosciences teams up with Primula for kidney disease study
14 May 2024 //
PHARMACEUTICAL TECHNOLOGY
Walden Positive WAL0921 Kidney Disease Phase 1+ Data
15 Apr 2024 //
GLOBENEWSWIRE
Walden Biosciences Announces First Subject Dosed in Phase 1 Trial of WAL0921
05 Jun 2023 //
GLOBENEWSWIRE
Walden Biosciences Promotes Curt Dewan, CFA to Chief Financial Officer
05 Apr 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support